Pages that link to "Q28139645"

The following pages link to Histopathology of genetically defined endometrial precancers (Q28139645):

Displaying 42 items.

• The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system (Q24646398) (← links)
• Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis (Q24647890) (← links)
• New concepts for an old problem: the diagnosis of endometrial hyperplasia (Q28071864) (← links)
• Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment? (Q28085485) (← links)
• Alteration of the k-ras gene expression in atypical and nonatypical hyperplastic endometrium (Q34082455) (← links)
• Nrf2 expression in endometrial serous carcinomas and its precancers (Q34467239) (← links)
• Genomics and proteomics in cancer (Q35134364) (← links)
• Endometrial Intraepithelial Neoplasia Clinical Correlates and Outcomes (Q35164066) (← links)
• Hertig and Beyond: A Systematic and Practical Approach to the Endometrial Biopsy (Q35569362) (← links)
• Diagnosis of premalignant endometrial disease (Q35586140) (← links)
• Does the radiofrequency impedance-controlled endometrial ablation have any morphologic effects on uterine leiomyomata? Report of 3 cases (Q36493879) (← links)
• Uterine stem cells: what is the evidence? (Q36588793) (← links)
• A primer of endometrial cytology with histological correlation (Q37002933) (← links)
• Diagnosing endometrial hyperplasia: why is it so difficult to agree? (Q37112463) (← links)
• The endometrial hyperplasias revisited (Q37251777) (← links)
• Altered PTEN expression; a diagnostic marker for differentiating normal, hyperplastic and neoplastic endometrium (Q37460521) (← links)
• Altered expression of fibroblast growth factor receptor 2 isoform IIIc: relevance to endometrioid adenocarcinoma carcinogenesis and histological differentiation (Q37676762) (← links)
• Molecular biomarkers in endometrial hyperplasias predict cancer progression (Q37842874) (← links)
• Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies (Q38258014) (← links)
• Loss of Mismatch Repair Protein Expression in Unselected Endometrial Adenocarcinoma Precursor Lesions (Q38710498) (← links)
• Paired boxed gene 1 expression: A single potential biomarker for differentiating endometrial lesions associated with favorable outcomes in patients with endometrial carcinoma (Q38844574) (← links)
• Comparative study of human eutopic and ectopic endometrial mesenchymal stem cells and the development of an in vivo endometriotic invasion model (Q39820860) (← links)
• Inverted (hobnail) high-grade prostatic intraepithelial neoplasia and invasive inverted pattern. (Q41995582) (← links)
• EIN and WHO94. (Q43010392) (← links)
• Reproducibility of current classifications of endometrial endometrioid glandular proliferations: further evidence supporting a simplified classification (Q43565064) (← links)
• P53 expression in spontaneous and estradiol-induced endometrial hyperplasia during menopause (Q44369959) (← links)
• PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus (Q44702044) (← links)
• Involution of PTEN-null endometrial glands with progestin therapy (Q48035535) (← links)
• The immunohistochemical profile of atypical eosinophilic syncytial changes vs serous carcinoma (Q50614421) (← links)
• The phosphatase PTPL1 is required for PTEN-mediated regulation of apical membrane size. (Q52431051) (← links)
• Reproducibility of endometrial intraepithelial neoplasia diagnosis is good, but influenced by the diagnostic style of pathologists. (Q53095157) (← links)
• [Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology]. (Q53279286) (← links)
• Clinical outcome in diagnostically ambiguous foci of ‘gland crowding’ in the endometrium (Q53308994) (← links)
• Using gene expression in patients with endometrial intraepithelial neoplasia to assess the risk of cancer. (Q55314741) (← links)
• The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma (Q79134590) (← links)
• Detection of endometrial intraepithelial neoplasia (EIN) in postmenopausal endometrium (Q79166196) (← links)
• Liquid-based Papanicolaou test (SurePath) interpretations before histologic diagnosis of endometrial hyperplasias and carcinomas: study of 272 cases classified by the 2001 Bethesda system (Q80544725) (← links)
• Problems with the current diagnostic approach to complex atypical endometrial hyperplasia (Q82209810) (← links)
• Immunohistochemical analysis of steroid receptors, proliferation markers, apoptosis related molecules, and gelatinases in non-neoplastic and neoplastic endometrium (Q82823750) (← links)
• PTEN-loss and nuclear atypia of EIN in endometrial biopsies can predict the existence of a concurrent endometrial carcinoma (Q85016483) (← links)
• DNA methylation as a biomarker for the detection of hidden carcinoma in endometrial atypical hyperplasia (Q86111497) (← links)
• Endometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancers (Q95806002) (← links)